Who is funding
beauty and skincare
in 2026.

Beauty is the category where the funding round and the acquisition are two acts of the same play. A brand raises, proves it can move product at speed, and then a strategic that has been watching pays up to own it. That lifecycle is why the funding board matters as much as the deal board. The Series A raised today often previews the brand a strategic acquires a year or two later. In 2026, that funding board is busy, disciplined, and pointed at a few very specific kinds of brand.

This is a living tracker of beauty and skincare funding in 2026, the companion to my beauty acquisition-multiples tracker, which covers the exit side. Read together, the two form the full lifecycle from first raise to final sale. This page sits under the broader 2026 consumer M&A window and feeds the consumer funding-rounds catch-all. Every figure traces to reputable deal data, and where a value is not disclosed, I say so.

I have raised the capital and, on the other side, run the diligence that decides whether a funded brand is actually worth acquiring. At WIN Brands Group we both raised and bought, so I know how a fundraise sets up an exit and how a sloppy raise can poison one. Beauty is unusually legible here, because the gross margins are high enough that the story is really about brand and velocity, and that is exactly what both investors and acquirers are underwriting.

Where the beauty
money went in early
2026.

Beauty funding stayed strong and selective into 2026. In Q1 alone, 19 beauty companies each raised at least $2.5 million, totaling just over $180 million collectively, per Playbook of Beauty. That is a healthy quarter, and the composition matters more than the total, because the money clustered around a few clear theses rather than spraying across the category. The only consumer category running hotter on both funding and M&A is drinks, and the year's functional and non-alcoholic beverage deals show how fast capital moves when a category is in favor.

Three patterns defined the quarter. Science-backed formulation was the common thread across skincare and haircare pure players, so clinical credibility did the fundraising work. AI-driven beauty emerged as a real category, led by Osmo's $70 million round for scent-molecule discovery. And brands with Latin roots rose, exemplified by Nopalera, built around the nopal cactus, and Ceremonia, a haircare label drawing on Latin American heritage, per Playbook of Beauty. K-beauty stayed resilient alongside them.

Geography told its own story. The US and India each produced seven funded companies in Q1 2026, making them the most active markets, per Playbook of Beauty. That is not random. It lines up with where the strategics say they are hunting, and it is a useful signal for any founder deciding where to build and raise. The money is concentrating, and knowing where it concentrates is half the battle, a theme that runs through consumer funding across every category in 2026.

The 2026 beauty
funding board.

Here are the named beauty and skincare rounds worth knowing from 2026 so far, with stage, amount, and lead or notable backer. The first seven rows are the early-2026 set; the six below them are the beauty entries the funding rounds tracker logged between July 28 and August 20, and two of those are not closed rounds at all: Lewie announced a $3M raise it is seeking, and Oliveda announced a listing it plans for 2027. Amounts trace to Playbook of Beauty, The Index, and company or investor disclosures. Where a stage or valuation was not disclosed, the cell is left open rather than guessed.

The two biggest rounds show where conviction is highest. Osmo's $70 million raise, the largest disclosed round of the quarter, went to an AI-driven fragrance startup that filed more fragrance patents in 2025 than all major perfume houses combined, per Playbook of Beauty. Evoluderm's $31 million from NextStage AM backed a French personal-care brand that tripled revenue to nearly €40 million over three years. Technology and proven growth are pulling the biggest checks now. Brand heat alone is not enough.

The mid-size rounds show the enduring playbook. Molly Sims' YSE Beauty closed a $15 million Series A led by Silas Capital with L Catterton participating, per Cosmetics Business, and science-backed SkinInspired raised a $2.66 million Series A with Unilever Ventures participating, per CB Insights. A founder with a distinct point of view, a credible clinical story, and the right consumer-fund backers is still a fundable beauty brand.

Who is writing the
beauty checks in
2026.

The beauty capital base in 2026 splits into three camps, and the most important shift is that the strategics are now in the earliest camp. Consumer-focused venture funds and growth investors write most of the rounds, private equity backs the proven scalers, and corporate venture arms increasingly take early positions in brands they may one day acquire. Knowing which camp is on your cap table shapes both your growth path and your eventual exit.

The consumer venture and growth camp still does the volume. Funds like Silas Capital, L Catterton, and Alter Equity back brands with a distinct identity and real demand, and they are underwriting the same thing an acquirer eventually will: a brand consumers actively choose and a velocity that can scale. This is the camp most beauty founders will raise from first, and its diligence is a useful preview of the exit conversation.

The strategic corporate venture camp is the one to watch. Unilever Ventures joining SkinInspired's Series A is a small check with a big signal: the strategic is getting close early, precisely because it is concentrating its beauty investment on the US and India, the two most active markets of the quarter, per Playbook of Beauty. When a corporate venture arm is on your early cap table, you are often being scouted as a future acquisition rather than simply funded, a dynamic that maps directly onto the most active consumer acquirers of 2026.

Why raising is the
on-ramp to a beauty
exit.

Beauty funding and beauty M&A are two stages of one lifecycle, not separate markets, and 2026 makes that connection unusually clear. Beauty is the hottest bet in consumer M&A in 2026, with strategics paying up for scaled brands, so a brand that raises and proves velocity is effectively building an audition tape for those buyers. The funding round is where the exit gets set up. Not every category works this way. In baby, kids and education brand M&A, the gap between a raise and a sale runs years longer, because buyers there underwrite trust and repeat purchase rather than velocity.

The exit side is loud. Recent beauty M&A includes e.l.f. Beauty acquiring Hailey Bieber's Rhode for up to $1 billion and Henkel agreeing to buy Olaplex, alongside larger strategic moves, per Forbes. Those are the outcomes the funded brands are aiming at, and the multiples on that exit side are exactly what I break down in the beauty acquisition-multiples tracker. The two pages are deliberately a pair. Beauty also gets read more honestly next to the rest of consumer, and the exit board across every consumer category is where you can see how those beauty prices compare with food, beverage and wellness.

The reason the lifecycle is so tight in beauty is margin. A 65 to 75% gross margin funds the marketing engine an acquirer is really buying, so a beauty brand that raises, uses the capital to build genuine velocity, and keeps its margin intact is building precisely the asset a strategic covets. A raise is not a guarantee of an exit. But the pattern holds across the brands I have operated and advised: funded, high-velocity, margin-healthy brands are the ones acquirers watch, and eventually buy.

What it means if
you are investing
or acquiring.

If you are investing in or acquiring beauty in 2026, fund and buy for a defensible reason to exist, because that is what the market is rewarding. The Q1 winners had one of three things in common: science-backed clinical credibility, genuine technology like Osmo's AI fragrance platform, or authentic cultural roots like the Latin-heritage brands. A beauty brand without one of those is a marketing bet, and marketing bets are exactly what get repriced when growth slows.

Get in early on the brands you would want to own. The Unilever Ventures move into SkinInspired is the template: a small early check into a science-backed brand in a priority market buys both optionality and information. For a strategic, an early minority stake in a fast-growing beauty brand is cheap relative to buying it later at a full acquisition multiple, and it puts you first in line when the founder is ready.

Underwrite velocity and margin, not follower count. Beauty's high gross margin is the whole reason the category commands premium exits, so a brand burning its margin on discounting to manufacture growth is destroying the exact asset that makes it valuable. The discipline is to fund and buy brands whose velocity is real and whose margin is intact, the same rigor I apply in the acquisition red flags worth catching early.

What it means if
you are raising or
building to sell.

If you are a beauty founder, the 2026 funding board tells you exactly what to build: a brand with a defensible reason to exist and velocity to prove it. Science, technology, or cultural authenticity are the theses drawing capital, so a clear, ownable answer to "why does this brand deserve to exist?" is the difference between a funded round and a passed one. A pretty brand with no defensible core is a hard raise now.

Choose your capital with the exit in mind. Taking an early check from a strategic's venture arm, as SkinInspired did with Unilever Ventures, can be a feature, because it puts a potential acquirer close and informed. But it also shapes your options, so go in clear-eyed about whether the goal is staying independent or being scouted. Both are valid; confusing them is not. The preparation barely changes either way, because what makes a brand fundable also makes it buyable.

Protect the margin that makes you valuable. Beauty's premium exits are funded by fat gross margins, so the temptation to buy growth through heavy discounting is the fastest way to lower your eventual sale price. Build velocity while keeping your margin intact, keep your economics clean, and know which strategic your brand would most strengthen, which is the core of making a brand genuinely sellable.

What to watch
through the rest
of the year.

Two threads are worth watching through the rest of 2026. The first is AI-driven beauty maturing from novelty to category. Osmo's $70 million round suggests investors now see defensible technology in beauty as well as brands, so watch for more capital into formulation, personalization, and discovery platforms, and for the strategics to start acquiring the winners rather than building their own.

The second is the funding-to-exit handoff accelerating. With strategics actively hunting and corporate venture arms taking early stakes, expect the gap between a brand's growth round and its acquisition to keep shrinking, especially in the US and India where the money is concentrating. The Q1 funding board is, in effect, a shortlist of future targets. I update this page as rounds and deals are announced, and this pass is current to September 1, 2026. The exit side sits in the beauty acquisition-multiples tracker.

Questions founders
and investors keep
asking.